All conditions

Osteoporosis

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

1665
Trials on record
126
Recruiting now
2
Australian sites
3
Phase 3 trials
10
PBS medicines
How these figures are counted
  • Trials on record is every trial tagged to this condition at any stage, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
  • Recruiting now counts only trials whose registry status is "Recruiting". Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
  • Australian sites counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
  • Phase 3 trials counts trials counted under "Recruiting now" that are at Phase 3.

Find recruiting trials for Osteoporosis →

Get alerts when Osteoporosis trials change ↗

Voxsanity currently covers 103 conditions. We are expanding coverage regularly.

Understanding Osteoporosis

Osteoporosis is a condition where bones gradually lose their density and strength, making them more fragile and easier to break. Healthy bone has a structure a bit like a honeycomb, with small spaces inside. With osteoporosis, those spaces become larger, meaning the bone becomes less solid overall. This can happen without any obvious symptoms, which is why it is sometimes called a "silent" condition — many people only find out they have it after breaking a bone from a minor fall or bump that would not normally cause a fracture.

In Australia, osteoporosis is very common. It affects approximately 1.2 million Australians, with women — particularly those who have gone through menopause — making up the majority of cases. However, it also affects men and younger people in some circumstances. Older age, family history, low calcium intake, smoking, and certain medications are among the factors that can increase a person's risk. Because it is so widespread, it is a significant focus of Australian health services and research.

When it comes to managing osteoporosis, care typically involves a combination of approaches. These often include looking at diet and lifestyle factors such as calcium and vitamin D intake, physical activity, and reducing fall risks at home. Healthcare providers may also discuss medications that help slow bone loss or support bone strength. Regular monitoring through bone density scans is also a common part of ongoing care. Your doctor or specialist is the best person to talk with about what options make sense for your individual situation.

This overview is an AI generated summary written from public medical sources and checked on a sample basis. It is general information, not medical advice or a diagnosis. Always speak with your doctor about your situation. How we use AI

Can you access treatment for Osteoporosis in Australia right now? Here's what's publicly known.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Updated regularly from public government registries

PBS-subsidised medicines for Osteoporosis

10 medicines listed on the PBS for Osteoporosis. Filter by authority type, or open the full table below.

What the authority types mean Unrestricted: no clinical criteria; a doctor can prescribe it on the PBS for any appropriate use. Restricted benefit: subsidised only for the specific conditions or uses set out by the PBS. Streamlined authority: restricted, but the doctor does not need prior approval; they record a streamlined authority code confirming you meet the criteria. Authority required: restricted, and the doctor must get prior approval from Services Australia (by phone or online) before it is subsidised. Source: Pharmaceutical Benefits Scheme (pbs.gov.au).
Full PBS medicines table 10 listed

These medicines are listed on the Pharmaceutical Benefits Scheme (PBS) for the specific indications shown. A listing does not mean a medicine is right for you; your doctor decides what is appropriate. Prices shown are the PBS-determined dispensed price. Most patients pay only the standard co-payment, up to AU$25.00 per script (general) or AU$7.70 (concession or Safety Net) in 2026, with the Australian Government subsidising the rest.

Medicine Brand(s) Listed for
Alendronate APO-Alendronate Established osteoporosis AU$3.64 Restricted benefit
Alendronate + colecalciferol Fosamax Plus 70 mg/140 mcg, Fosamax Plus Established osteoporosis AU$6.67 Streamlined authority
Calcitriol Rocaltrol Established osteoporosis AU$14.99 Streamlined authority
Denosumab Jubbonti Established osteoporosis AU$159.38 Streamlined authority
risedronate Actonel, Actonel EC, APO-Risedronate +1 more Established osteoporosis AU$18.99 Restricted benefit
Zoledronic acid Zoledasta Established osteoporosis AU$57.23 Streamlined authority
Alendronate APO-Alendronate Osteoporosis AU$3.64 Restricted benefit
Alendronate + colecalciferol Fosamax Plus 70 mg/140 mcg, Fosamax Plus Osteoporosis AU$6.67 Streamlined authority
Calcium Cal-500, CAL-600 Osteoporosis AU$5.18 Restricted benefit
Denosumab Jubbonti Osteoporosis AU$159.38 Streamlined authority
risedronate Actonel, Actonel EC, APO-Risedronate +1 more Osteoporosis AU$18.99 Restricted benefit
Zoledronic acid Zoledasta Osteoporosis AU$57.23 Streamlined authority
Alendronate APO-Alendronate Corticosteroid-induced osteoporosis AU$3.64 Restricted benefit
Alendronate + colecalciferol Fosamax Plus 70 mg/140 mcg, Fosamax Plus Corticosteroid-induced osteoporosis AU$6.67 Streamlined authority
risedronate Actonel, Actonel EC, APO-Risedronate +1 more Corticosteroid-induced osteoporosis AU$18.99 Restricted benefit
Zoledronic acid Zoledasta Corticosteroid-induced osteoporosis AU$57.23 Streamlined authority
Romosozumab Evenity established osteoporosis Severe AU$352.24 Authority required
Teriparatide Terrosa, Ritosa established osteoporosis Severe AU$149.55 Streamlined authority
Raloxifene Evista Established post-menopausal osteoporosis AU$15.66 Streamlined authority

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.

Research pipeline

Where trials for Osteoporosis currently sit in the development pipeline. The funnel shape shows how few drugs reach later phases in general; the counts are this condition's actual trial numbers.

Phase success rates are industry-wide historical averages, not predictions for specific trials. Learn how trials work →

Most active research sponsors

Organisations with the most recruiting trials for Osteoporosis.

View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile

Where trials are running

Clinical trial sites for Osteoporosis by country. Australia is highlighted.

Showing the top 10 of 51 countries with trial sites.

Clinical trials for Osteoporosis

Showing 130 of 130 trials

The plain English eligibility text on each trial below is an AI generated summary of the official criteria, checked on a sample basis. How we use AI

🇦🇺 NCT00111241 · Monash University Not Applicable · 1 country Completed
Completed Not Applicable Est. completion 1 May 2011
🇦🇺 AU

**Who might be able to join this trial:** **Group 1 (main group):** - You are between 40 and 65 years old - You are a woman who has had breast surgery and still has your uterus (you have not had a hysterectomy) - You have been taking aromatase inhibitor medication (a type of hormone-blocking drug used after breast can...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT00808132 · Pfizer Phase 3 · 12 countries Completed
Completed Phase 3 Est. completion 1 February 2011
🇦🇷 AR🇦🇺 AU🇨🇱 CL🇨🇴 CO🇩🇰 DK🇫🇮 FI🇭🇺 HU🇲🇽 MX +4 more

Who might be able to join this trial: - Women aged 40 to 64 who are generally healthy, have gone through menopause, and are looking for treatment to help with menopause symptoms - Women who have not had a period for at least 12 months on their own, OR have not had a period for at least 6 months and have hormone test re...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT00939874 · St Vincent's Hospital, Sydney Phase 4 · 1 country Completed
Completed Phase 4 Est. completion 1 June 2012
🇦🇺 AU

**Who might be able to join this trial:** - You are willing and able to give written consent to participate - You are an adult aged 18 or older who is living with HIV - You have been on a stable HIV treatment regimen that includes two specific medications (tenofovir/TDF and a type of drug called a boosted protease inhi...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
🇦🇺 NCT01631214 · Amgen Phase 3 · 42 countries Completed
Completed Phase 3 Est. completion 27 February 2017
🇦🇷 AR🇦🇺 AU🇦🇹 AT🇧🇪 BE🇧🇷 BR🇧🇬 BG🇨🇦 CA🇨🇱 CL +34 more

**Who might be able to join this trial:** - You are a woman who has gone through menopause - Your bone density scan (at the hip) shows a T-score of -2.50 or lower, AND you have had at least one moderate or severe spinal (vertebral) fracture, OR at least two mild spinal fractures - Your bone density scan (at the hip) sh...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT04608630 · Australian and New Zealand Intensive Care Research Centre Phase 2 · 2 countries Recruiting
Recruiting Phase 2 Est. completion 28 February 2027
🇦🇺 AU🇳🇿 NZ

**Who might be able to join this trial:** - Women aged 50 or older, or men aged 70 or older - People who have been in the Intensive Care Unit (ICU) for at least 2 full days and are not expected to leave the ICU on that second day - People who have needed a significant level of ICU support — such as breathing machines,...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT06487130 · Bespoke Clinical Research Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2073
🇦🇺 AU

Who might be able to join this trial: - You must be aged 18 or older and living in Australia. Who may not be able to join: - There are no stated exclusion criteria for this trial. Important: Always verify eligibility with the trial site directly before applying.

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT00024804 · National Institute of Dental and Craniofacial Research (NIDCR) Not Applicable · 1 country Recruiting
Recruiting Not Applicable
🇺🇸 US

**Who might be able to join this trial:** - You must be at least 1 day old (this trial is open to all ages, including newborns, children, and adults) - You have a known or suspected bone disease, shown by things like a fracture, unusual bone findings on an X-ray, CT scan, MRI, or bone density test, or a personal or fam...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01747291 · University Health Network, Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇨🇦 CA

Who might be able to join this trial: - People who are older than 20 years of age - People who have had an incomplete atypical femur fracture (a specific type of thigh bone stress fracture) that meets the official diagnostic guidelines set by an international bone health expert group (ASBMR), or a low-force or no-force...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02150850 · McGill University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇨🇦 CA

"Who might be able to join this trial: - You are 45 years of age or older - You are a man or woman living in Quebec who has had, or is currently having, a specific type of unusual thigh bone (femur) fracture called an atypical femoral fracture (AFF) — this includes both complete breaks and partial cracks, as identified...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02635022 · National Taiwan University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇹🇼 TW

**Who might be able to join this trial:** - People aged 50 or older who also meet at least one of the following conditions: - People who have recently had a hip fracture and are being treated in an orthopaedic ward - People in a geriatric ward where an X-ray has newly identified a spinal (vertebral) fracture, or peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02719314 · Prof Dr Frank Buttgereit Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇩🇪 DE

**Who might be able to join this trial:** - You have been diagnosed with a long-term inflammatory rheumatic disease or psoriasis (or, for the control group, you have not been diagnosed with these conditions) - You are currently taking, have previously taken, or are expected to start a long-term steroid (glucocorticoid)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02958020 · Shanghai University of Traditional Chinese Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇨🇳 CN

Who might be able to join this trial: - People who are permanent residents of the relevant area. - Women between the ages of 45 and 79, or men between the ages of 50 and 79. Who may not be able to join: - People with severe mental health conditions, serious physical illnesses, or acute infectious diseases that would m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03461237 · Beijing Jishuitan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇨🇳 CN

Who might be able to join this trial: - You have been diagnosed with osteoporosis (a condition that weakens bones) - You have had a hip fracture due to osteoporosis (specifically a break at the top of the thigh bone, either at the neck or the trochanter region) - You are willing and able to take part in the study and h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03699228 · Beijing Jishuitan Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇨🇳 CN

Who might be able to join this trial: - You are between 30 and 90 years old - You are attending a health check-up and are having a low-dose CT scan of your chest Who may not be able to join: - You are pregnant - You have a metal implant in the area of your body being scanned by the CT machine Important: Always verify...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03755193 · Shinshu University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 23 November 2024
🇯🇵 JP

Who might be able to join this trial: - You have been diagnosed with osteoporosis (a condition that causes weak and brittle bones) Who may not be able to join: - You do not have osteoporosis - You are allergic to the drugs being used in this trial (confirm with trial site) - You do not wish to take part in the researc...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03921060 · University of Texas Southwestern Medical Center Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 July 2027
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with Cystic Fibrosis (CF), confirmed by a sweat test or genetic analysis - People (and their parents or legal guardians, if applicable) who are able to read and write in English Who may not be able to join: - People who do not have a Cystic Fibrosi...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04704947 · Sherief Abd-Elsalam Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 October 2030
🇪🇬 EG

**Who might be able to join this trial:** - Men and women aged 50 or older who have been diagnosed with osteoporosis (weakened bones) - People with either high blood pressure or normal blood pressure are welcome - People whose bone density scan (DEXA scan) shows a T-score of -2.5 or lower, meaning their bone density is...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04730622 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇮🇹 IT

**Who might be able to join this trial:** - People who have had a hip (femoral neck) fracture that likely happened due to osteoporosis — meaning it occurred with little or no significant injury — and who are being treated with a hip replacement surgery. - People who are mentally able to understand the study and have si...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04741906 · Copenhagen University Hospital at Herlev Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇩🇰 DK

**Who might be able to join this trial:** - People who have cancer or osteoporosis and are being treated with medication that slows bone loss (called antiresorptive treatment) - People who are willing and able to attend all the planned check-ups and assessments required by the trial - People who are expected to live fo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04787679 · Laura Maria Vergani Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 9 July 2026
🇮🇹 IT

Who might be able to join this trial: - You must be 18 years of age or older - You are having your first hip replacement surgery (not a revision or repeat procedure) - You are willing and able to sign a consent form agreeing to take part - You are already scheduled to have a routine CT scan before your surgery as part...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04796350 · AgNovos Healthcare, LLC Not Applicable · 11 countries Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇦🇹 AT🇧🇪 BE🇨🇦 CA🇩🇰 DK🇫🇷 FR🇩🇪 DE🇮🇹 IT🇯🇵 JP +3 more

**Who might be able to join this trial:** - The person is a woman who has gone through menopause, has not had a period for at least one year, and is between 65 and 91 years old. - The person has had a hip fracture caused by a minor incident (such as a low-level fall) and is scheduled to have surgery to repair that hip...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05132348 · University Hospital, Bonn Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 February 2026
🇩🇪 DE

Who might be able to join this trial: - Adults aged 18 or older who have been diagnosed with osteoporosis. - People who are willing and able to provide written consent to participate. Who may not be able to join: - People who have not been diagnosed with osteoporosis. - People who are not willing or able to provide wr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05202678 · AgNovos Healthcare, LLC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇧🇪 BE

**Who might be able to join this trial:** - You are a woman who has gone through menopause and has not had a period for at least one year - Your hip bone scan (DXA) shows a T-score of -2.5 or lower, meaning you have significant bone loss from osteoporosis in your hip - At least one of your hips has never had surgery or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05228262 · University Hospital, Clermont-Ferrand Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇫🇷 FR

Who might be able to join this trial: - Women aged 50 or older who have been diagnosed with postmenopausal osteoporosis (with or without a fracture) and for whom a doctor has decided to start treatment with bone-strengthening medications, such as bisphosphonates, raloxifene, teriparatide, denosumab, or romosozumab, tak...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05237570 · Universidad de Murcia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 December 2026
🇪🇸 ES

Who might be able to join this trial: - You must be older than 18 years of age - You must have low levels of plaque and gum bleeding (less than 30% when measured by a dentist) - You must have a specific anatomical feature where the sinus cavity dips into the area between the roots of your upper first molar (confirm wit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05246813 · Imelda Hospital, Bonheiden Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2028
🇧🇪 BE

Who might be able to join this trial: - People aged 65 years or older Who may not be able to join: - People who have a known blood condition, such as myelodysplasia, leukemia, or cancer - People who are not able to provide written consent to participate in the trial Important: Always verify eligibility with the trial...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05266976 · VA Office of Research and Development Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 60 or older who are veterans - People who live in the Denver Metro Area - People who are generally active, such as those who regularly walk or cycle for recreation **Who may not be able to join:** - People whose kidneys are not functioning well enough (based on a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05571514 · Centre Hospitalier Universitaire de Saint Etienne Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇫🇷 FR

Who might be able to join this trial: - Women who have gone through menopause and are between 50 and 65 years old - People whose bone density scan results fall in a range that suggests lower than normal bone density but not yet full osteoporosis (a T-score between -1 and -3) - People who have not had any broken bones c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05688969 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2028
🇺🇸 US

Who might be able to join this trial: - Women aged over 45 years who have gone through menopause - People who meet the menopause criteria in one of two ways: either more than 36 months have passed since their last natural period, or more than 36 months have passed since a hysterectomy, with a specific hormone level (FS...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05704036 · Johns Hopkins University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 January 2027
🇺🇸 US

**Who might be able to join this trial:** **Main Study:** - You have been diagnosed with cystic fibrosis (CF) - You are female and have had at least one menstrual period - You are willing to stay on the same type of estrogen supplement (or none at all) for the whole study **Feasibility Sub-Study (in addition to the a...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05732870 · Relation Therapeutics Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇬🇧 GB

Who might be able to join this trial: - People with osteoarthritis who are having joint replacement, bone realignment, or joint fusion surgery on any joint, including the hip, knee, shoulder, wrist, elbow, or ankle. - People with a broken hip bone who are having a partial or full hip replacement, or another type of sur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05764733 · Wake Forest University Health Sciences Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 January 2028
🇺🇸 US

**Who might be able to join this trial:** - People who live independently in their own home or community (not in a care facility) - People with a body mass index (BMI) over 30, or a BMI between 25 and 30 with at least one additional health risk factor (confirm with trial site for what counts as a risk factor) - People...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05787808 · Meddoc Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 September 2025
🇳🇴 NO

**Who might be able to join this trial:** - People of any gender who are 55 years of age or older and have been diagnosed with osteopenia (a condition where bone density is lower than normal but not low enough to be called osteoporosis, defined by a T-score below 0.0 but higher than -2.5 on a bone density scan) **Who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05845021 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇺🇸 US

Who might be able to join this trial: - You are over 50 years old - You have been diagnosed with osteoporosis confirmed by a DEXA scan (a type of bone density scan) Who may not be able to join: - You have previously been diagnosed with osteoporosis before this trial - You have previously received any treatment for ost...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05866029 · Peking Union Medical College Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who have recently had a brittle (fragility) hip fracture - People who have recently had a brittle (fragility) spinal fracture - People who have recently had a brittle (fragility) fracture at another location in the body, and/or have a bone density scan result below a c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05904353 · University Hospital, Akershus Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇳🇴 NO

Who might be able to join this trial: - People aged 75 years or older who have had a hip fracture Who may not be able to join: - People who do not wish to receive treatment - People for whom a different osteoporosis treatment has been recommended by their doctor - People who do not live in the area covered by the admi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05906147 · Second Xiangya Hospital of Central South University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 27 February 2021
🇨🇳 CN

**Who might be able to join this trial:** - You are 40 years old or older and have had a bone density scan (a type of X-ray called a DEXA scan) done at the health management center of the hospital running this trial - You are able to make your own decisions and are willing to take part, and you agree to sign a consent...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05923736 · University Hospital, Clermont-Ferrand Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 4 October 2025
🇫🇷 FR

**Who might be able to join this trial:** **For all participants:** - Adults (male or female) - People who are able to give their consent to take part in research - People who are enrolled in a French Social Security health plan **For the finger osteoarthritis group:** - People who are seen as outpatients in the Rheu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05946278 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2030
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 85 years old who are having a major spinal surgery, such as a fusion connecting many levels of the spine down to the pelvis, a surgery that removes and reshapes bone in the spine, or any major spinal correction surgery where the surgeon expects to remove and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06041789 · Duke University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 November 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with cognitive impairment, confirmed through clinical assessment, brain imaging, or lab tests - People who are willing to start treatment for their cognitive impairment - Women who are either older than 55 years, or under 55 years and have not h...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06059222 · University of Aarhus Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 August 2030
🇩🇰 DK

**Who might be able to join this trial:** - Women who have been through menopause for at least two years - Women whose bone density scan shows a T-score below -2.5 at the lower spine, hip, or upper thigh bone (indicating osteoporosis) - Women who have had a bone fracture in the last 3 years at the spine, hip, pelvis, s...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06118905 · Susan L. Greenspan Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 28 February 2029
🇺🇸 US

**Who might be able to join this trial:** - You are a man or woman aged 65 or older who is able to walk (even with assistance) - You live in a nursing home, assisted living facility, or senior community - You have been diagnosed with osteoporosis (weak or thinning bones), which may have been confirmed by a bone density...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06134908 · Third Affiliated Hospital, Sun Yat-Sen University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have lived in the same city as the hospital for at least six months - People aged 50 years or older who are currently in hospital with a fracture - People who have never had a fracture before - People who have never been diagnosed with osteoporosis before being adm...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06164795 · 424 General Military Hospital Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇬🇷 GR🇮🇹 IT

**Who might be able to join this trial:** - Women who have gone through menopause, have been diagnosed with severe osteoporosis, and have recently completed a full course of treatment with either romosozumab or teriparatide (two specific bone-strengthening medications) **Who may not be able to join:** - People who hav...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06265246 · University of Saskatchewan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇨🇦 CA

**Who might be able to join this trial:** - You are between 19 and 30 years old - You get less than 1,000 mg of calcium per day from your diet - You live in or around Saskatoon, Saskatchewan, Canada **Who may not be able to join:** - You get more than 800 mg of calcium per day in total from food and supplements combin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06270758 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 November 2030
🇮🇹 IT

**Who might be able to join this trial:** - Women of Caucasian background who have gone through menopause and live in the Emilia-Romagna region - Women who reached menopause at age 45 or older **Who may not be able to join:** - People who have or have had cancer (tumours) - People who do not live independently (for ex...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06371755 · Paola Pisani Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇮🇹 IT

Who might be able to join this trial: - People who are already scheduled to have a lumbar and/or femoral DXA scan (a type of bone density scan) - People who are female - People aged between 30 and 80 years old (for the repeatability part of the study), or between 50 and 70 years old (for the accuracy part of the study)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06379243 · The Seventh Affiliated Hospital of Sun Yat-sen University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - You have been diagnosed with broken bones in your spine (in the chest or lower back area) caused by osteoporosis (a condition that weakens bones), based on the 2022 guidelines for osteoporotic fractures - A scan called an MRI has clearly shown signs of a fresh/recent fracture...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06389539 · Hebrew SeniorLife Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇺🇸 US

Who might be able to join this trial: - People aged 60 years or older. - People who have given written consent to take part and are available and willing to follow the study requirements for the entire study period. - People whose bone density scan (DXA) of the hip and spine shows a T-score above -2.5 (meaning bone den...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06395883 · Diakonhjemmet Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇳🇴 NO

**Who might be able to join this trial:** - You have been diagnosed with an inflammatory rheumatic joint disease (a condition where the immune system causes painful swelling in the joints, such as rheumatoid arthritis) - You are about to start a disease-modifying treatment (medication that slows down the disease) with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06431867 · Bradford Institute for Health Research Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2025
🇬🇧 GB

**Who might be able to join this trial:** *For older women:* - You have been diagnosed with osteoporosis, either told by a doctor or recorded in your medical records - You are aged 70 years or older - You live independently in your own home in the community (not in a care home) *For healthcare professionals:* - You c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06449742 · IRCCS San Raffaele Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2026
🇮🇹 IT

Who might be able to join this trial: - Participants must be male. - Participants must be aged 50 years or older. - Participants must have clinical and medical history information available from a CT scan of the abdomen and chest. - Participants must be willing and able to sign a consent form agreeing to take part in t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06454617 · Istituto Ortopedico Rizzoli Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇮🇹 IT🇳🇿 NZ

Who might be able to join this trial: - Both men and women of any background or ethnicity are welcome to participate. - You must be 18 years old or older. - You are already scheduled to have a CT scan of your lower back or abdomen for any medical reason (no specific condition is required). - The CT scan must be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06455085 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2029
🇺🇸 US

**Who might be able to join this trial:** - You are 50 years of age or older (there is no upper age limit) - You had a bone fracture in the last 12 months that happened from a minor injury (such as a simple fall) affecting the hip, thigh bone, pelvis, spine, upper arm, or wrist - You have a regular family doctor or pri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06462833 · Gazi University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2024
Turkey (Türkiye)

Who might be able to join this trial: - People who have gone through menopause - People who have been attending regular outpatient appointments for osteoporosis for at least one year Who may not be able to join: - People with bone, joint, muscle, or nerve conditions that could make it difficult to take part in exercis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06488872 · University Department of Geriatric Medicine FELIX PLATTER Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇨🇭 CH

**Who might be able to join this trial:** - You have had a CT scan (covering the chest, abdomen, pelvis, and spine) taken at the hospital's radiology department within one month before or after your inpatient stay — this applies to the sarcopenia (muscle loss) part of the study. - You have had both a CT scan of the ch...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06525688 · National and Kapodistrian University of Athens Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 October 2024
🇬🇷 GR

Who might be able to join this trial: - Postmenopausal women who have had a hip fracture (specifically a type called a subcapital femoral neck fracture) caused by osteoporosis (Arm 1) - Postmenopausal women who have hip osteoarthritis and are scheduled to have a total hip replacement surgery (Arm 2) Who may not be abl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06541548 · Centre Hospitalier Universitaire de Saint Etienne Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2035
🇫🇷 FR

**Who might be able to join this trial:** **For patients (people being studied for bone health concerns):** - Men or women receiving care at Saint-Etienne University Hospital who are at risk of osteoporosis (weak bones) - People who have previously broken a bone due to weak or fragile bones - People who have been reco...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06551155 · Istituto Ortopedico Rizzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 December 2026
🇮🇹 IT

Who might be able to join this trial: - People who are generally healthy and attending regular check-ups or outpatient visits for preventive health screening - People who have been diagnosed with low bone density (osteopenia) and have had a bone density scan (DXA) done - People who have been diagnosed with osteoporosis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06558188 · Massachusetts General Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 December 2027
🇺🇸 US

Who might be able to join this trial: - Women who are 45 years of age or older - Women who have gone through menopause - Women who have been diagnosed with osteoporosis and are considered at high risk of bone fractures Who may not be able to join: - Women who have previously used treatments that significantly affect b...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06606769 · Poznan University of Physical Education Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇵🇱 PL

"Who might be able to join this trial: - People who are women Who may not be able to join: - People who have been diagnosed with osteoporosis (a condition that causes bones to become weak and brittle) Important: Always verify eligibility with the trial site directly before applying."

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06608862 · Bundeswehr University Munich Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2026
🇩🇪 DE

Who might be able to join this trial: - Adults between 18 and 35 years old - Female - Willing to participate using a pseudonym (a false name to protect identity) - Currently serving as an occupational (professional) soldier - Free from any ongoing or current muscle or joint injuries Who may not be able to join: - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06643780 · Prince of Wales Hospital, Shatin, Hong Kong Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 April 2027
🇨🇳 CN

**Who might be able to join this trial:** - People aged 65 years or older, of any gender - People who have been diagnosed with both sarcopenia (low muscle mass and either low grip strength or poor physical performance, measured using specific tests and a body scan) and osteoporosis (low bone density, with a specific sc...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06652061 · Bangladesh University of Engineering and Technology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 March 2025
Bangladesh

Who might be able to join this trial: - You are 18 years of age or older (male or female) - You are willing to take part and have agreed to allow your X-ray images and health information to be used for research - You have had X-ray images of both your hip and spine, as well as a bone density scan (DEXA scan) - Your med...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06655701 · Beylikduzu State Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 January 2025
Turkey (Türkiye)

Who might be able to join this trial: - Women who have gone through menopause and have had a bone density scan (DXA) done within the last 6 months. - Women whose bone density scan results show either normal bone density (T-scores of -1 or above at the hip and spine) for the control group, or osteoporosis (T-scores of -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06717581 · IRCCS Azienda Ospedaliero-Universitaria di Bologna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 11 April 2025
🇮🇹 IT

Who might be able to join this trial: - You are over 60 years old - You have one or more long-term, non-infectious health conditions (such as diabetes or high blood pressure) that are being treated with medication - You are currently taking a medication combination called BIC/TAF/FTC (also known as Biktarvy) at the tim...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06728462 · Universal Integrated Corp. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 14 December 2025
🇹🇼 TW

Who might be able to join this trial: - Women who have gone through menopause and are between 60 and 90 years old - People whose bone density scan results show bones that are weak enough to be considered osteoporosis (a T-score below -2.5 at the spine or hip), but not lower than -4.0 at either site - People who either...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06731608 · Brigham and Women's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2028
🇺🇸 US

Who might be able to join this trial: - You are 65 years old or older - You were living in the community (such as in your own home or an apartment) when you broke a bone - You are staying at a participating skilled nursing facility (a short-term rehabilitation center) to recover from a broken bone in your lower body, i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06745544 · Aalborg University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇩🇰 DK

**Who might be able to join this trial:** - You are a man or woman aged 65 or older with either Type 1 or Type 2 diabetes - You live in your own home - You were diagnosed with diabetes at least one year ago - You are willing and able to sign a consent form to take part in the study - You have some previous experience w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06767150 · University Hospital, Toulouse Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 October 2030
🇫🇷 FR

**Who might be able to join this trial:** - You are a woman who has gone through menopause and has been diagnosed with osteoporosis (thinning of the bones) - You have been taking a medication called denosumab for at least 2 years, and your doctor has decided it is time to stop it because your treatment has gone well (n...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06776003 · Spine Centre of Southern Denmark Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇩🇰 DK

Who might be able to join this trial: - You are 50 years old or older and have been diagnosed with painful spinal fractures caused by osteoporosis (brittle bones), located in the middle or lower back area. - You have tenderness or pain when the affected area of your spine is touched. - Your fracture has been confirmed...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06791044 · Dionyssiotis, Yannis, M.D. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇬🇷 GR

Who might be able to join this trial: - People who have been diagnosed with a neurological disorder (a condition affecting the brain, spinal cord, or nerves) - Healthy people with no medical conditions who can take part as a comparison group (controls) Who may not be able to join: - People who are unable to fully unde...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06804590 · Mabwell (Shanghai) Bioscience Co., Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 April 2026
🇨🇳 CN

Who might be able to join this trial: - Women aged 50 to 80 years old who are able to walk around freely - Women whose bone density scan (a type of scan called a DXA) shows a T-score between -4.0 and -2.5 at the spine, hip neck, or total hip — meaning bone density is low but not severely low - Women who have at least o...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06812481 · Balikesir University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 November 2025
Turkey (Türkiye)

Who might be able to join this trial: - People who have been diagnosed with rheumatoid arthritis Who may not be able to join: - People who have a systemic (whole-body) disease that affects bone metabolism, or who are taking medications that affect bone metabolism - People who have metal implants or materials in their...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06838702 · IRCCS Azienda Ospedaliero-Universitaria di Bologna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 January 2028
🇮🇹 IT

Who might be able to join this trial: - You must be over 18 years old - You are receiving a liver transplant, for any medical reason - You are able to have a bone density scan carried out - You are able to have blood tests or other checks related to bone and mineral health carried out - You are willing and able to give...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06851676 · ANTIMO Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 July 2025
🇮🇹 IT

Who might be able to join this trial: - People who have been diagnosed with primary osteopenia (low bone density) or osteoporosis (weak, brittle bones), with or without sarcopenia (low muscle mass and strength), based on current medical guidelines and standard diagnostic criteria. Who may not be able to join: - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06853132 · Yale University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with a lumbar disc herniation (a slipped disc in the lower back) and osteoporosis (weakened, brittle bones), based on their medical records and clinical assessment. - Female patients aged 45 or older, or male patients aged 50 or older. - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06864130 · Odense University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 March 2029
🇩🇰 DK

Who might be able to join this trial: - You must be female - You must be postmenopausal - You must currently be taking a bone medication called Alendronate - You have been taking Alendronate for more than 3 years AND have not had any bone fractures, OR you have been taking Alendronate for more than 5 years AND your mos...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06867952 · S.LAB (SOLOWAYS) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2026
🇷🇺 RU

**Who might be able to join this trial:** - Adults between 40 and 75 years old who have been diagnosed with low bone density or bone loss (called osteopenia or osteoporosis), confirmed by a bone scan called a DXA scan, with a T-score of -1.0 or lower - People with stable eating habits who are willing to keep their cur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06889415 · Konya Beyhekim Training and Research Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2025
Turkey (Türkiye)

**Who might be able to join this trial:** - People who have been diagnosed with Rheumatoid Arthritis (RA) based on recognised international diagnostic guidelines (the ACR/EULAR 2010 criteria) - People who are female or male and are over the age of 50 - People who have the mental and physical ability to complete the stu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06915935 · The Second Hospital of Shandong University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 65 or older who have lived in the local area for more than 6 months within the past year **Who may not be able to join:** - People who have a diagnosed cognitive impairment (such as dementia) or a mental illness **Important: Always verify eligibility with the tr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06938152 · National Taiwan University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 April 2029
🇹🇼 TW

**Who might be able to join this trial:** - You are a woman who has gone through menopause and are between 50 and 90 years old - Your bone density scan shows a T-score of -3.0 or lower in at least one bone in your lower spine (meaning significantly low bone density) - You are physically and mentally able to understand...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06946316 · University of Saskatchewan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2027
🇨🇦 CA

Who might be able to join this trial: - Women who have gone through menopause (there is no upper or lower age limit for women) - Men who are 50 years of age or older Who may not be able to join: - People who are currently taking medications that may affect bone health - People whose health conditions may make it unsaf...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06947213 · Beylikduzu State Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 May 2025
Turkey (Türkiye)

Who might be able to join this trial: - Women between the ages of 55 and 75 years old - Women who have been diagnosed with osteoporosis based on a bone density scan (DXA) done within the last six months - Women in a similar age range who have not been diagnosed with osteoporosis and would participate as healthy compari...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06950463 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇪🇬 EG

Who might be able to join this trial: - Women who have gone through menopause, meaning their periods stopped at least 12 months ago - Women between 50 and 60 years old - Women with a body mass index (BMI) — a measure of body weight relative to height — below 30 - Women with a vitamin D level that is low but not severel...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07027306 · AO Foundation, AO Spine Not Applicable · 14 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇦🇷 AR🇧🇷 BR🇨🇱 CL🇪🇬 EG🇫🇮 FI🇩🇪 DE🇮🇳 IN🇯🇵 JP +6 more

**Who might be able to join this trial:** - Women aged 50 or older who have gone through menopause (defined as having no menstrual periods for one full year), or men aged over 60. - People who have been diagnosed with one or more new, painful spine fractures in the mid-to-lower back region (from the upper back down to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07030205 · University Hospital, Clermont-Ferrand Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇫🇷 FR

**Who might be able to join this trial:** **For people with osteoporosis:** - Women aged 50 or older who have been diagnosed with postmenopausal osteoporosis by a rheumatologist, whether or not they have had a fracture - People who are able to give their consent to take part in the research - People who are affiliated...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07062978 · Qilu Pharmaceutical Co., Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 January 2027
🇨🇳 CN

**Who might be able to join this trial:** - People who agree to take part in the study and sign a consent form. - Women who have gone through menopause, are able to walk without assistance, and are between 50 and 85 years old (inclusive). - People whose bone density scan results in the lower back or hip area show a T-...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07083557 · Bettina Mittendorfer Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2030
🇺🇸 US

**Who might be able to join this trial:** - People who are aged 18 to 100 years old - People whose body mass index (a measure of body weight relative to height) falls between 16.0 and 60 kg/m² **Who may not be able to join:** - People younger than 18 or older than 100 years old - People whose body mass index is below...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07105163 · Procare Health Iberia S.L. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇪🇸 ES

Who might be able to join this trial: - Women who have been diagnosed with postmenopausal osteoporosis - Women who have been prescribed a monthly or weekly oral bisphosphonate (a type of bone-strengthening medication) along with a daily calcium and vitamin D supplement (in sachet or chewable tablet form), with this tre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07120997 · Penn State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2029
🇺🇸 US

Who might be able to join this trial: - You are between 44 and 55 years old - Your body mass index (a measure of body weight relative to height) is below 35, meaning you are not severely overweight - You are considered generally healthy, based on a health questionnaire, a physical check-up with a nurse practitioner, an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07141043 · Grigore T. Popa University of Medicine and Pharmacy Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇷🇴 RO

**Who might be able to join this trial:** *Hemodialysis (HD) group:* - You have been receiving kidney dialysis (hemodialysis) for at least 12 months and are between 20 and 70 years old, and you are willing to sign a consent form. *Kidney Transplant (KTR) group:* - You received a kidney transplant at least 12 months a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07143669 · Blueprint Medicines Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2028
🇺🇸 US

**Who might be able to join this trial:** **Group 1 (Mast Cell Activation)** — People who meet the criteria for either of the following: - People who have had a documented severe allergic reaction (anaphylaxis) to insect stings (such as bees or wasps) that affected the heart or blood circulation, OR a severe allergic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07162168 · Peking University People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇨🇳 CN

Who might be able to join this trial: - Adults aged 18 years or older - People who have already had a routine abdominal CT scan done without contrast dye - People whose CT scan images included the upper part of the thigh bone (the area near the hip joint) - People whose CT scan was done for a reason unrelated to bones...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07187518 · POROUS GmbH Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇩🇪 DE

Who might be able to join this trial: - People who are female or male, aged between 21 and 55 years (inclusive) - People who have given written agreement to take part in the trial Who may not be able to join: - People who have conditions that would interfere with bone scanning measurements, such as fractures, metal im...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07189260 · University Hospital Bispebjerg and Frederiksberg Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2029
🇩🇰 DK

Who might be able to join this trial: - People who have had a hip fracture, regardless of their age - People who are cognitively well-functioning (thinking and memory are not impaired) - People who are able to understand what the study involves and agree to take part - People who can speak and understand Danish - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07191353 · Odense University Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 March 2027
🇩🇰 DK

**Who might be able to join this trial:** - You are a woman between 60 and 75 years old, of any ethnicity. - A bone density scan (DXA scan) done within the last 6 months shows your bone strength is lower than normal but not yet at the level of osteoporosis (a T-score between lower than -1.0 and higher than -2.5). - Yo...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07228611 · Ankara Etlik City Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
Turkey (Türkiye)

Who might be able to join this trial: - You have had an ischemic stroke (caused by a blockage) or a hemorrhagic stroke (caused by bleeding in the brain) - Either between 1 week and 6 months have passed since your stroke, or more than 1 year has passed since your stroke - You are between 55 and 85 years old Who may not...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07231822 · Kirsehir Ahi Evran Universitesi Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - Women who have gone through menopause and are between 50 and 75 years old - People who have been diagnosed with osteoporosis based on a bone density scan result (called a DEXA scan), with a T-score of -2.5 or lower - People who have been in menopause for at least one year - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07236658 · Ankara Etlik City Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who are female - People who are 18 years of age or older - People who are scheduled to have surgery for breast cancer affecting one breast only Who may not be able to join: - People who would not be able to attend follow-up visits as required by the trial - People who hav...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07242612 · Khyber Medical University Peshawar Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 March 2026
🇵🇰 PK

**Who might be able to join this trial:** - Women who have gone through menopause and have not had a menstrual period for at least one year - Women who are older than 50 years of age - People who have been diagnosed with primary osteoporosis (bone loss not caused by another condition or medication) - People who are not...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07253493 · Istanbul Physical Medicine Rehabilitation Training and Research Hospit... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
Turkey (Türkiye)

Who might be able to join this trial: - You must be postmenopausal (your periods have permanently stopped). - For the **osteoporosis group**: you must have been diagnosed with osteoporosis in the hip area, shown by specific bone density scan scores at the femoral neck or total hip (T-score of -2.5 or lower). - For the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07254429 · Martin Blomberg Jensen Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2027
🇩🇰 DK

**Who might be able to join this trial:** - Women who are older than 40 and up to 65 years of age at the screening visit - People with a body mass index (a measure of weight relative to height) between 18 and 35 - People who have confirmed menopause, either by having had no periods naturally for 12 or more consecutive...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07256769 · Regina Elena Cancer Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 September 2027
🇮🇹 IT

**Who might be able to join this trial:** - You are a white/Caucasian woman between 35 and 70 years old - You have been diagnosed with breast cancer and are being treated with certain hormone-blocking medications (aromatase inhibitors, or tamoxifen combined with hormone-suppressing injections, or both) that were starte...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07271771 · Aarhus University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 March 2027
🇩🇰 DK

Who might be able to join this trial: - Women who have been through menopause for at least two years - Women aged 40 years or older - Women whose bone density scan results show a T-score of -2.0 or higher (meaning bone density is not severely low) - Women who have at least two lower spine bones that can be measured by...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07281586 · National Taiwan University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2028
🇹🇼 TW

Who might be able to join this trial: - Women who have gone through menopause, are between 50 and 85 years old, and have had a broken bone related to osteoporosis or low bone density (osteopenia). - Men who are between 50 and 85 years old and have had a broken bone related to osteoporosis or low bone density (osteopeni...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07283887 · National Taiwan University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 July 2026
🇹🇼 TW

Who might be able to join this trial: - Women who have gone through menopause and are over 50 years of age, with a bone density scan result showing osteoporosis (a T-score of -2.5 or lower at the spine, hip, or femoral neck) - Women who have never taken any medication for osteoporosis, whether by injection or by mouth...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07288684 · University of Waterloo Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇨🇦 CA

Who might be able to join this trial: - People who are over the age of 50, including men and women who have gone through menopause - People who have had a spinal bone fracture within the last two years - People who are willing to take part in 12 online rehabilitation sessions over 10 weeks - People who have access to t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07296471 · Dr. Li Chen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2027
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older with normal bone density, confirmed by a special bone scan called a DXA scan, and no history of bone diseases, major organ problems, or long-term inflammatory or immune conditions (this group serves as healthy comparison participants) - Adults aged 18...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07301749 · Amber Implants B.V. Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 31 July 2027
🇫🇷 FR🇩🇪 DE

Who might be able to join this trial: - You are between 21 and 85 years old - You have a single spinal fracture caused by compression (not a burst or twisting injury) located in the mid or lower back area of the spine - Your fracture is either less than 6 weeks old, or imaging shows it may still be possible to correct...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07303166 · University Hospital, Strasbourg, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇫🇷 FR

Who might be able to join this trial: - You are a doctor based in the Alsace region who treats older patients with osteoporosis (a condition that weakens bones) - You have had the chance to use a practical guide about osteoporosis at some point Who may not be able to join: - You are a doctor who has never had the oppo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07325578 · Precision IO Group Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇺🇸 US

Who might be able to join this trial: - People who are 22 years of age or older - People who have been approved by their doctor to have a CT- or CBCT-guided procedure on the pelvis or spine (not including the neck area) performed under general anesthesia - People who have signed a consent form that has been approved by...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07333989 · Mohamed Said Alsafy Alhamrawy Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 5 April 2026
🇪🇬 EG

**Who might be able to join this trial:** - People who have been diagnosed with osteoporosis, confirmed by a bone density scan (DEXA scan) showing a T-score of -2.5 or lower - People between the ages of 65 and 75 years old - People with a body mass index (BMI) between 25 and 29.9 (considered in the overweight range) -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07334626 · Benha University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2026
🇪🇬 EG

**Who might be able to join this trial:** - Women who have had breast cancer and are between 40 and 60 years old - People whose breast cancer was confirmed through laboratory testing and was at an early to middle stage (stage I, II, or III) - People who have been taking a type of hormone therapy called aromatase inhib...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07365514 · University of Connecticut Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 February 2028
🇺🇸 US

**Who might be able to join this trial:** - Women aged 45 to 70 years who have gone through menopause, with their last menstrual period no more than 10 years ago - People who have not used hormone replacement therapy for at least one year before the study begins - People who currently exercise less than 7 hours per we...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07367776 · University Hospital, Linkoeping Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 October 2028
🇸🇪 SE

Who might be able to join this trial: - You are a woman or a man - You are over 50 years old - You have been diagnosed with osteoporosis or low bone density (osteopenia), either through an official diagnosis in your medical records or because you are currently taking or have previously taken medication for osteoporosis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07412782 · Meyer Children's Hospital IRCCS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 June 2026
🇮🇹 IT

Who might be able to join this trial: - A parent or legal guardian (or the patient themselves if an adult) has given written consent to participate - The patient is between 5 and 18 years of age - People of any sex or ethnicity may be eligible - The patient has a known medical condition that negatively affects bone hea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07419451 · Bandırma Onyedi Eylül University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
Turkey (Türkiye)

Who might be able to join this trial: - Women who are 65 years of age or older - Men who are 70 years of age or older Who may not be able to join: - People who have problems with thinking, memory, or mental processing (cognitive dysfunction) - People who have been diagnosed with dementia - People who have a psychiatri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07421713 · Promedius Inc Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇳🇱 NL🇬🇧 GB

**Who might be able to join this trial:** - You are 50 years of age or older at the time your chest X-ray was taken - You have had a chest X-ray (taken from the front, called a PA view) and a bone density scan (called a DXA scan) performed within 6 months of each other - Both your chest X-ray and bone density scan wer...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07474571 · Peking University People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are 18 years old or older - Both men and women are welcome to participate - You have already had relevant bone imaging done, such as an X-ray, CT scan (without contrast), or MRI (without contrast) - The bones in the area being studied have a normal structure, with no birt...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07508553 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 23 December 2026
🇮🇹 IT

**Who might be able to join this trial:** - People who have signed a consent form and are willing to take part and complete the study questionnaires - Pregnant women who are between 35 and 41 weeks along at the time of joining the study - Women carrying one baby or twins (including both types of twin pregnancies) - Wo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07546552 · Peter Humaidan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 March 2028
🇩🇰 DK

Who might be able to join this trial: - Women aged 18 or older who have normal AMH levels (a hormone that indicates ovarian reserve) - People who are able to give their informed consent to participate Who may not be able to join: - People who have previously had ovarian tissue removed and transplanted back into their...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07579936 · Shenzhen Salubris Pharmaceuticals Co., Ltd. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 July 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are a woman who can move around independently, and you are between 45 and 80 years old - Your periods stopped naturally at least 3 years ago, OR you had surgery to remove your ovaries at least 3 years ago (the surgery must have been done after age 40); if your menopause...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07597850 · Tri-Service General Hospital (TSGH) Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 October 2026
🇹🇼 TW

Who might be able to join this trial: - People aged 65 years or older at the time of screening. - People with a Body Mass Index (a measure of body weight relative to height) below 30. - People identified as "pre-frail" based on a recognised frailty assessment, meaning they meet 1 or 2 out of 5 specific signs of physica...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07616401 · Istituto Auxologico Italiano Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2029
🇮🇹 IT

Who might be able to join this trial: - You must be female - You must have gone through menopause (your periods have stopped) - You must have been diagnosed with osteoporosis (weak or thinning bones) based on a bone density scan - You must be eating a normal amount of calcium in your diet - You must be taking a vitamin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07620834 · Taichung Veterans General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 17 June 2026
🇹🇼 TW

Who might be able to join this trial: - You are between 40 and 80 years old - You have been identified as being at higher risk for osteoporosis based on a specific screening tool that uses your age and weight (confirm with trial site) - You have had a chest X-ray taken within the past year Who may not be able to join:...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07621679 · McGill University Health Centre/Research Institute of the McGill Unive... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇨🇦 CA

**Who might be able to join this trial:** - People who are 70 years of age or older, of any gender - People who are able to walk on their own, with or without a walking aid such as a cane or walker - People who have broken a bone after the age of 40, OR who have had two or more falls in the past 12 months, OR whose bon...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07665424 · Juin-Hong Cherng Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇹🇼 TW

**Who might be able to join this trial:** - People aged 40 to 95 years old, of any gender - People who have been admitted to hospital with a spinal fracture (a collapsed vertebra) caused by either osteoporosis or an injury - People whose fracture is located in a specific section of the mid-to-lower spine (between the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07677033 · Kanuni Sultan Suleyman Training and Research Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
Turkey (Türkiye)

**Who might be able to join this trial:** - People aged 18 years or older - People who attend a Physical Medicine and Rehabilitation outpatient clinic - People who are already scheduled to have a routine bone density scan (called a DXA scan) as part of their normal clinical care - People who are physically able to perf...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07677072 · Kanuni Sultan Suleyman Training and Research Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - People who are female - People aged 45 years or older - People who have gone through menopause - People who are already attending a Physical Medicine and Rehabilitation outpatient clinic - People who are already having a routine bone density scan (DEXA) and related blood test...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Advocacy and support in Australia

Organisations that can offer information, support, or connection for Osteoporosis. Where more than one is listed, they serve different needs or regions, so choose whichever fits your situation.

Healthy Bones Australia, formerly Osteoporosis Australia, supports bone health and people affected by osteoporosis.

This is a starting point, not medical advice or an endorsement. Contact details change; search the organisation name to find its current website.